Difference between revisions of "Drug toxicity"
Jump to navigation
Jump to search
(→Proton pump inhibitor: +more) |
|||
| Line 21: | Line 21: | ||
</gallery> | </gallery> | ||
=Specific drugs= | |||
==Proton pump inhibitor== | ==Proton pump inhibitor== | ||
{{Main|Proton pump inhibitor effect}} | {{Main|Proton pump inhibitor effect}} | ||
==Nonsteroidal anti-inflammatory drugs== | |||
*{{Main|Nnonsteroidal anti-inflammatory drugs}} | |||
==Oral contraceptive pill== | |||
{{Main|Oral contraceptive pill}} | |||
=See also= | =See also= | ||
Revision as of 15:35, 5 September 2014
Drug toxicity, also drug reaction, in pathology is often a diagnosis of exclusion. Few drugs leave a distinctive histomorphologic pattern.
This article covers a few of the distinctive histomorphologic pattern and links to other articles that deal with specific organ systems.
Liver drug toxicity
Luminal gastrointestinal pathology
Sodium polystyrene sulfonate
- AKA Kayexalate (trade name).
General
- Used to treat hyperkalemia.
Microscopic
Features:[1]
- Purple blobs on H&E stain - look somewhat like calcium phosphate.
- Can cause focal necrosis.
Image
Kayexalate crystals and adenocarcinoma. (WC)
Specific drugs
Proton pump inhibitor
Main article: Proton pump inhibitor effect
Nonsteroidal anti-inflammatory drugs
- Main article: Nnonsteroidal anti-inflammatory drugs
Oral contraceptive pill
Main article: Oral contraceptive pill
See also
References
- ↑ Abraham SC, Bhagavan BS, Lee LA, Rashid A, Wu TT (May 2001). "Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings". Am. J. Surg. Pathol. 25 (5): 637-44. PMID 11342776. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0147-5185&volume=25&issue=5&spage=637.